NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
17.34
+0.40 (2.36%)
Jan 22, 2026, 1:03 PM EST - Market open
NeuroPace Employees
NeuroPace had 184 employees as of December 31, 2024. The number of employees increased by 13 or 7.60% compared to the previous year.
Employees
184
Change (1Y)
13
Growth (1Y)
7.60%
Revenue / Employee
$515,565
Profits / Employee
-$130,359
Market Cap
577.56M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 184 | 13 | 7.60% |
| Dec 31, 2023 | 171 | 4 | 2.40% |
| Dec 31, 2022 | 167 | 1 | 0.60% |
| Dec 31, 2021 | 166 | 14 | 9.21% |
| Dec 31, 2020 | 152 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Varex Imaging | 2,400 |
| Avanos Medical | 2,227 |
| Orthofix Medical | 1,616 |
| Tactile Systems Technology | 1,037 |
| Bioventus | 930 |
| Standard BioTools | 818 |
| Cytek Biosciences | 648 |
| Cerus | 630 |
NPCE News
- 7 days ago - NeuroPace, Inc. (NPCE) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 9 days ago - NeuroPace Reports Preliminary Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook - Business Wire
- 22 days ago - NeuroPace to Present at the 44th Annual J.P. Morgan Healthcare Conference - Business Wire
- 5 weeks ago - NeuroPace Files PMA Supplement to FDA Seeking Expanded RNS® System Indication for Idiopathic Generalized Epilepsy - Business Wire
- 6 weeks ago - NeuroPace Announces Positive 18-Month NAUTILUS Trial Results in Idiopathic Generalized Epilepsy - Business Wire
- 7 weeks ago - NeuroPace to Highlight Life-Changing Outcomes and AI-Powered Confident Care at the 2025 American Epilepsy Society (AES) Annual Meeting - Business Wire
- 2 months ago - NeuroPace Announces Favorable Medicare Reimbursement Increases for RNS System Physician and Hospital Outpatient Services - Business Wire
- 2 months ago - NeuroPace, Inc. (NPCE) Q3 2025 Earnings Call Transcript - Seeking Alpha